Clinical Trial Update: Subcutaneous Testosterone Enanthate Safety in Adult Men Diagnosed With Hypogonadism [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the safety of subcutaneous testosterone enanthate in adult men with hypogonadism has completed and results were posted in March 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypogonadism

Drugs mentioned

• XYOSTED (Testosterone enanthate)

Snippet

Sponsor: Antares Pharma Inc. | Conditions: Hypogonadism | Phase 3 | Status: COMPLETED | Results posted: 2018-03-30